"Pillar of scientific expertise" passes away
This article was originally published in Clinica
Executive Summary
Edward Arquilla, board member for in vitro diagnostic cancer test firm Radient Pharmaceuticals (RPC), has died. Dr Arquilla joined RPC in 1997 and helped with its corporate and scientific planning. He also served as the firm’s liaison to the clinical and academic communities. Douglas MacLellan, executive chairman and CEO of RPC, said that Dr Arquilla “has been a pillar of scientific, medical and business expertise and insight for RPC for more than a dozen years”. Dr Arquilla obtained the very first patent for a pregnancy test in 1964. He was also a full-time faculty member of the department of pathology at the University of Southern California, the University of California at Los Angeles and the University of California at Irvine.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals